Keywords: atrix, releases, news, eligard, canada, usa, laboratories

Atrix releases news on Eligard in Canada

Article | 15 March 2004

The USA's Atrix Laboratories has reported that its licensee for Eligard (leuprolide acetate for injection), Sanofi-Synthelabo Canada, received notice of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Eligard

Leuprolide Acetate

Amino Acids

Injection

Physostigmine Salicylate

Go to drug listing